You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Phase I study of intermittent and chronomodulated oral therapy with capecitabine in patients with advanced and/or metastatic cancer
BMC Cancer, February 2006
Daniele Santini, Bruno Vincenzi, Gaia Schiavon, Annalisa La Cesa, Simona Gasparro, Angelo Vincenzi, Giuseppe Tonini
The data shown below were compiled from readership statistics for 26 Mendeley readers of this research output. Click here to see the associated Mendeley record.
|Readers by professional status||Count||As %|
|Student > Master||6||23%|
|Student > Ph. D. Student||3||12%|
|Student > Bachelor||2||8%|
|Readers by discipline||Count||As %|
|Medicine and Dentistry||12||46%|
|Nursing and Health Professions||3||12%|
|Agricultural and Biological Sciences||3||12%|
|Sports and Recreations||2||8%|
|Pharmacology, Toxicology and Pharmaceutical Science||1||4%|